Jian Qin

1.5k total citations
48 papers, 987 citations indexed

About

Jian Qin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jian Qin has authored 48 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 21 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Jian Qin's work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers) and MicroRNA in disease regulation (5 papers). Jian Qin is often cited by papers focused on RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers) and MicroRNA in disease regulation (5 papers). Jian Qin collaborates with scholars based in China, United States and Czechia. Jian Qin's co-authors include Yuqin Pan, Xiangxiang Liu, Shukui Wang, Huiling Sun, Bei Pan, Mu Xu, Lin Kang, Tao Xu, Xueni Xu and Li Sun and has published in prestigious journals such as Environmental Science & Technology, PLoS ONE and Chemical Communications.

In The Last Decade

Jian Qin

45 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian Qin China 18 569 374 149 149 108 48 987
Anna Kakehashi Japan 20 463 0.8× 250 0.7× 110 0.7× 151 1.0× 125 1.2× 89 1.0k
Junhua Zheng China 22 638 1.1× 327 0.9× 285 1.9× 192 1.3× 91 0.8× 70 1.3k
Xiang Zhou China 22 618 1.1× 366 1.0× 211 1.4× 193 1.3× 73 0.7× 57 1.2k
Constantin Ștefani Romania 12 673 1.2× 320 0.9× 222 1.5× 320 2.1× 88 0.8× 38 1.2k
Hong Yan China 21 593 1.0× 340 0.9× 243 1.6× 317 2.1× 119 1.1× 70 1.2k
Shuguang Zhu China 17 493 0.9× 240 0.6× 160 1.1× 210 1.4× 118 1.1× 48 1.1k
Zongfu Pan China 19 596 1.0× 310 0.8× 140 0.9× 182 1.2× 64 0.6× 67 989
David Wu United States 11 1.1k 1.9× 510 1.4× 169 1.1× 193 1.3× 99 0.9× 21 1.6k
Haibo Long China 18 492 0.9× 308 0.8× 86 0.6× 80 0.5× 61 0.6× 38 952
Huayao Li China 22 731 1.3× 422 1.1× 178 1.2× 199 1.3× 54 0.5× 55 1.2k

Countries citing papers authored by Jian Qin

Since Specialization
Citations

This map shows the geographic impact of Jian Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Qin more than expected).

Fields of papers citing papers by Jian Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Qin. The network helps show where Jian Qin may publish in the future.

Co-authorship network of co-authors of Jian Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Qin. A scholar is included among the top collaborators of Jian Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Qin. Jian Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Jian, Yuhan Chen, Mu Xu, et al.. (2025). Hypoxia Promotes Malignant Progression of Colorectal Cancer by Inducing POSTN+ Cancer‐Associated Fibroblast Formation. Molecular Carcinogenesis. 64(4). 716–732. 5 indexed citations
2.
Zhu, Zhou, et al.. (2025). Computational analysis of DEHP’s oncogenic role in colorectal cancer. Discover Oncology. 16(1). 848–848. 1 indexed citations
4.
Yu, Dongmei, Wei Peng, Jiansheng Cai, et al.. (2022). JAK2/STAT3 Signaling Pathway and Klotho Gene in Cadmium-induced Neurotoxicity In Vitro and In Vivo. Biological Trace Element Research. 201(6). 2854–2863. 6 indexed citations
5.
Wang, Yuqin, et al.. (2022). Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer. Frontiers in Endocrinology. 13. 829879–829879. 8 indexed citations
6.
Li, Chenmeng, Bei Pan, Xuhong Wang, et al.. (2022). Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis. Journal of Cancer Research and Clinical Oncology. 148(8). 1965–1982. 19 indexed citations
7.
Li, Chenmeng, Bei Pan, Xiangxiang Liu, et al.. (2021). Long intergenic non-coding RNA LINC00485 exerts tumor-suppressive activity by regulating miR-581/EDEM1 axis in colorectal cancer. Aging. 13(3). 3866–3885. 9 indexed citations
8.
Xu, Mu, Xueni Xu, Bei Pan, et al.. (2019). LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Molecular Cancer. 18(1). 135–135. 206 indexed citations
9.
Lü, Huiling, Jian Qin, Wenbo Wang, et al.. (2019). Biochanin A Provides Neuroprotection Against Cerebral Ischemia/Reperfusion Injury by Nrf2-Mediated Inhibition of Oxidative Stress and Inflammation Signaling Pathway in Rats. Medical Science Monitor. 25. 8975–8983. 75 indexed citations
10.
Deng, Shan, Xu Liu, Heming Lu, et al.. (2017). Three-Phase Adaptive Radiation Therapy for Patients With Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiation Therapy: Dosimetric Analysis. Technology in Cancer Research & Treatment. 16(6). 910–916. 11 indexed citations
12.
Wu, Yi‐Ying, Xing Zhang, Zhengzhao Li, et al.. (2017). Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN. Food & Function. 8(3). 1061–1066. 61 indexed citations
13.
Li, Zhixiang, Mingxing Teng, Jian Qin, et al.. (2017). The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia. Bioorganic & Medicinal Chemistry Letters. 27(10). 2210–2215. 12 indexed citations
14.
Wu, San‐Gang, Qiang Li, Fang Peng, et al.. (2016). The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus. PLoS ONE. 11(2). e0149822–e0149822. 39 indexed citations
15.
Qin, Jian, et al.. (2015). Effect of blood type on survival of Chinese patients with esophageal squamous cell carcinoma. OncoTargets and Therapy. 8. 947–947. 8 indexed citations
16.
Wang, Lan, Rikang Wang, Minghua Jin, et al.. (2014). Carvedilol Attenuates 6-Hydroxydopamine-Induced Cell Death in PC12 Cells: Involvement of Akt and Nrf2/ARE Pathways. Neurochemical Research. 39(9). 1733–1740. 34 indexed citations
17.
Chen, Jian, Xu Chen, & Jian Qin. (2011). Effects of polysaccharides of the Euphoria Longan (Lour.) Steud on focal cerebral ischemia/reperfusion injury and its underlying mechanism. Brain Injury. 25(3). 292–299. 11 indexed citations
19.
Lu, Heming, Yanrong Hao, Jiaxin Chen, et al.. (2009). Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A treatment paradigm also applicable to patients in Southeast Asia. Cancer Treatment Reviews. 35(4). 345–353. 42 indexed citations
20.
He, Min, Jian Qin, Rihong Zhai, et al.. (2008). Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approach. Proteome Science. 6(1). 10–10. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026